HOME >> BIOLOGY >> NEWS
Blocking COX-1 slows tumor growth in mice

Blocking the COX-1 enzyme not COX-2 might lead to a way to prevent and treat the most common and fatal form of ovarian cancer, researchers at Vanderbilt University Medical Center reported this week.

The finding, that COX-1 inhibition slowed the growth of epithelial ovarian tumors in a mouse model of the disease, is surprising, said Sudhansu K. Dey, Ph.D., senior author of the paper and director of the Division of Reproductive and Developmental Biology in the Vanderbilt Department of Pediatrics.

Previous studies have linked high levels of another cyclooxygenase enzyme, COX-2, to colorectal and other cancers. "But this is the exception," said Dey, also professor of Cell & Developmental Biology and Pharmacology.

"These results establish the foundation for further studies and clinical trials using the novel approach of targeting COX-1 for the prevention and treatment of ovarian cancer," the researchers concluded.

Dey said further studies should be conducted to determine whether aspirin and other non-steroidal anti-inflammatory drugs, which block both COX enzymes, might improve treatment of epithelial ovarian cancer.

The study, posted Sunday on the Web site of the journal Cancer Research, was led by Takiko Daikoku, Ph.D., research assistant professor of Pediatrics at Vanderbilt.

According to the American Cancer Society, more than 22,000 women in the United States will be diagnosed with ovarian cancer this year, and more than 16,000 will die from the disease. Ovarian cancer is the fourth leading cause of cancer death in American women after lung, breast and colorectal cancer.

Eighty-five percent of human ovarian tumors arise from the epithelium or surface layer of tissue that surrounds the ovaries. While the incidence of ovarian cancer has declined recently, the death rate has not, in part because it is difficult to diagnose the disease in the early stages.

Several previous studies have reported high COX-2 levels in ovari
'"/>

Contact: Clinton Colmenares
clinton.colmenares@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
1-May-2005


Page: 1 2 3

Related biology news :

1. Blocking beta1-integrin to treat cancer
2. Blocking a premature aging syndrome with anticancer drugs
3. Blocking blood vessels provides new option for large group of advanced lung cancer patients
4. Blocking PLK-1 to beat bladder cancer
5. Blocking neurodegeneration by radiation and bone marrow transfer prevents inherited glaucoma in mice
6. Blocking cell signaling can stymie viral infections, study shows
7. Blocking cell suicide switch fails to stop prion damage in mouse brains
8. New understanding of COX-1 and COX-2 enzymes could revise classification of pain meds
9. Protein found that slows hepatitis C growth in liver cells
10. Aerosol pollution slows down winds and reduces rainfall
11. Diabetes slows nerve recovery after heart transplant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2019)... ... September 25, 2019 , ... Deep Science Ventures ... UK, the world’s largest independent funder of cancer research. , Deep Science Ventures was ... a systems-level view of the opportunity from the start, both at the industry and ...
(Date:9/22/2019)... (PRWEB) , ... September 20, 2019 , ... ... instrument makers are adjusting to client demands for precision medicine products. The report, ... demand exceeding $19 billion in 2018, the pharma/bio sector is the largest source ...
(Date:9/14/2019)... CULVER CITY, Calif. (PRWEB) , ... September 13, ... ... of the World Molecular imaging Society (WMIS) focused on non-invasive real-time tracking of ... With mean survival rate of five years (and most cases fatal) lysomal storage ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... ... September 24, 2019 , ... ... of high-level X-ray methods using synchrotron-produced X-rays to study amorphous drug formulations. ... present “Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: ...
(Date:9/24/2019)... , ... September 24, 2019 , ... ... Hannah Holscher, PhD, RD, to its Scientific Advisory Board. Dr. Holscher is an ... and the Division of Nutritional Sciences at the University of Illinois Urbana-Champaign, where ...
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, ... four months old, Tucker was limping and lame on his right hip and elbow. ... and it was called “the worst case the vet had seen.” He was prescribed ...
(Date:9/17/2019)... Fla. (PRWEB) , ... September 16, 2019 , ... ... broadcast Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings ... Biomedical Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated ...
Breaking Biology Technology:
Cached News: